Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Burn Injuries01:22

Burn Injuries

2.4K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
2.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

469
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
469
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

5.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.6K
Introduction to Hemostasis01:05

Introduction to Hemostasis

5.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Are Routine Labs Necessary? Postoperative Electrolyte Trends in Lipedema Patients Undergoing Liposuction: Insights from a Single-Center Retrospective Cohort.

Aesthetic plastic surgery·2026
Same author

Authors' Response to "Vasopressors in Early Burn Resuscitation: Physiological Concerns Revisited".

Acta anaesthesiologica Scandinavica·2026
Same author

Performance of Sepsis-3 criteria in burn patients: A multicenter real-world study.

Burns : journal of the International Society for Burn Injuries·2026
Same author

Impact of Hypothyroidism on Short-Term and Long-Term Outcomes of Coronary Artery Bypass Graft Surgery.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Risk of Malignancy with Immunosuppressive Drugs Used in Organ Transplants Compared to Those Used for Non-Transplant Indications.

Cancers·2026
Same author

Utilising Single Cell Analysis and Spatial Transcriptomics to Elucidate Molecular Mechanisms of Wound Healing: A Literature Review.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2026
Same journal

Challenges in Antimicrobial Treatment and Antimicrobial Stewardship in Hospital-Acquired Infections in Adult Burn Patients.

European burn journal·2026
Same journal

Bridging the Evidence-Practice Gap in Early Burn Injury Care: A Comprehensive Evidence Synthesis of Global Guidelines, Consensus, and Systematic Reviews for Resource-Limited Settings.

European burn journal·2026
Same journal

Automated Classification of Second- and Third-Degree Burn Images Using Convolutional Neural Networks.

European burn journal·2026
Same journal

A Single-Centre Review of Outcomes of Delayed Admission to a Burns Unit.

European burn journal·2026
Same journal

Simulation Enhances Resident Preparedness Using Skin Cell Suspension Autograft.

European burn journal·2026
Same journal

The 4th Educational Course of the European Burns Association (EBA).

European burn journal·2026
查看所有相关文章

相关实验视频

Updated: Jun 6, 2025

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes
02:49

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes

Published on: February 23, 2024

1.0K

非类固醇抗炎药物 降低严重烧伤患者凝血病的发生率

Lyndon Huang1, Kassandra Corona1, Kendall Wermine1

  • 1School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.

European burn journal
|November 27, 2024
PubMed
概括
此摘要是机器生成的。

非类固醇抗炎药物 (NSAIDs) 显著减少严重烧伤患者的凝血病,败血症和死亡率. 早期的NSAID使用在灼伤伤害的急性阶段提供保护性益处.

关键词:
在TriNetX数据库中,我们可以使用TriNetX数据库.国际标准化比率 (INR) 是指国际标准化比率.死亡率 死亡率这是一项回顾性研究.这是一种血症.

更多相关视频

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
07:45

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment

Published on: November 6, 2018

9.7K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

241

相关实验视频

Last Updated: Jun 6, 2025

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes
02:49

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes

Published on: February 23, 2024

1.0K
Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
07:45

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment

Published on: November 6, 2018

9.7K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

241

科学领域:

  • 创伤外科 手术 创伤外科
  • 药理学 药理学是指药理学的学科.
  • 关键护理医学 关键护理医学

背景情况:

  • 烧伤引起的凝血病是一种严重的并发症,会影响患者的治疗结果.
  • 早期干预策略对于管理严重烧伤至关重要.
  • 非类固醇抗炎药物 (NSAIDs) 有潜在的抗炎和止痛特性.

研究的目的:

  • 调查早期非类固醇抗炎药物 (NSAID) 给药对燃烧引起的凝血病的影响.
  • 评估NSAIDs对严重烧伤患者死亡率和败血症发展的影响.
  • 确定NSAID在严重烧伤的急性阶段的保护作用.

主要方法:

  • 使用TriNetX研究网络进行的回顾性队列研究.
  • 严重烧伤患者 (TBSA> 20%) 在烧伤后的第一个星期内接受NSAIDs的鉴定.
  • 在匹配后,统计分析比较NSAID和非NSAID组之间的凝血病,败血症和死亡率.

主要成果:

  • 使用NSAID与炎症引起的凝血病的显著减少有关 (17.7%与32.3%,p < 0.0001).
  • 接受NSAID治疗的患者的败血症 (p < 0.01) 和死亡率 (p < 0.0001) 显著降低.
  • 无 NSAID 组也显示出血小板缩的显著降低 (p < 0.001).

结论:

  • 在严重烧伤的患者中,NSAIDs的早期使用显示出显著的保护作用.
  • 无 NSAIDs 降低燃烧引起的凝血病,败血症和急性阶段死亡的风险.
  • 无抗炎药是一种潜在的治疗选择,可以改善严重烧伤管理的结果.